Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01137877 · ClinicalTrials.gov registry record · Phase 3
Growth and Tolerance of Healthy Term Infants to a New Infant Formula
A Phase 3 study, sponsored by Abbott Nutrition.
- Terminated
- Registry status
- Phase 3
- Development phase
- 399
- Enrollment target
NCT01137877: Clinical Trial Phase 3 study, sponsored by Abbott Nutrition.
NCT01137877 is a Phase 3 study that was terminated before completion, run by Abbott Nutrition. The registered enrollment target is 399 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (48% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01137877, a Phase 3 study, was terminated before completion, sponsored by Abbott Nutrition.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 399 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the effect of two experimental milk-based infant formulas on the growth and gastrointestinal (GI) tolerance of term infants.
Interventions
- OTHER Human Milk
- OTHER Milk based infant formula powder
- OTHER Investigational Infant Formula #1
- OTHER Investigational Infant Formula #2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-10 |
| Phase | Phase 3 |
Why NCT01137877 stopped before completion
NCT01137877 is an interventional study that assigns participants to a tested intervention. The registered 399 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (48% lower).
The record links to 0 conditions, and to 4 interventions - of which Human Milk is the first listed.
NCT01137877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01137877 about?
NCT01137877 is a clinical study titled "Growth and Tolerance of Healthy Term Infants to a New Infant Formula". The objective of this study is to evaluate the effect of two experimental milk-based infant formulas on the growth and gastrointestinal (GI) tolerance of term infants.
What is the current status of trial NCT01137877?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 399 participants. The study started on 2010-05. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01137877?
The interventions under investigation include: Human Milk (OTHER), Milk based infant formula powder (OTHER), Investigational Infant Formula #1 (OTHER), Investigational Infant Formula #2 (OTHER).
Who is sponsoring clinical trial NCT01137877?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01137877's enrollment target sits among peer trials
399 962nd of 2000 higher than 1,038 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia